Candriam Equities L Biotechnology Class I GBP CapRegister to Unlock Ratings |
Growth Of 1000 (GBP) | 31/10/2024 |
|
Annual Returns (GBP) | 31/10/2024 | |||||||
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 31/10 | |
Price Return | 16.06 | -4.56 | 28.66 | 17.29 | -1.63 | 9.66 | 1.50 | 9.18 |
+/- Category | 5.77 | 3.41 | 8.46 | -8.68 | 7.40 | 17.50 | 2.79 | 7.73 |
+/- Category Index | 0.87 | -2.71 | 11.95 | -15.65 | -1.93 | 7.20 | -5.83 | 3.37 |
% Rank in Category | 22 | 32 | 14 | 61 | 35 | 3 | 30 | 13 |
Trailing Returns (GBP) | 21/11/2024 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | 0.46 | -0.24 | 0.67 |
1 Week | -3.44 | 1.26 | -0.14 |
1 Month | -4.29 | 0.50 | 3.44 |
3 Months | -5.04 | -2.13 | 8.57 |
6 Months | 4.71 | 3.86 | 13.64 |
YTD | 6.57 | 7.13 | 5.76 |
1 Year | 22.46 | 7.42 | 15.77 |
3 Years Annualised | 5.43 | 10.05 | 3.53 |
5 Years Annualised | 7.40 | 2.63 | -1.14 |
10 Years Annualised* | 12.36 | 5.23 | 4.09 |
Category: Sector Equity Biotechnology | |||
Category Index: Morningstar Gbl Biotechnology NR USD |
Quarterly Returns (GBP) | 31/10/2024 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | 3.71 | 2.98 | -0.37 | - |
2023 | -5.08 | -0.50 | -0.62 | 8.13 |
2022 | -4.89 | -0.25 | 12.79 | 2.48 |
2021 | -5.73 | 6.89 | 0.69 | -3.04 |
2020 | -4.92 | 25.51 | -5.56 | 4.07 |
2019 | 13.85 | 1.54 | -5.89 | 18.26 |
|
Advertisement |